In vitro activity of BMY-28142 in comparison with those of other beta-lactam antimicrobial agents.

The in vitro susceptibility of 406 clinical isolates to BMY-28142, a new semisynthetic cephem, was evaluated and compared with cefpimizole, HR 810, ceftazidime, cefotaxime, moxalactam, and cefoperazone in a broth microdilution assay. On a weight basis, the activity of BMY-28142 against Escherichia c...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Tsuji, A, Maniatis, A, Bertram, M A, Young, L S
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 1985
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180087/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3839120/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.4.515
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!